Javier Cortes, MD, PhD, International Breast Cancer Center, discusses the role of immunotherapy in the first line treatment of metastatic triple-negative breast cancer, presented at the 2021 Great…
Margaret Gatti-Mays, MD, MPH, FACP, Pelotonia Institute for Immuno‑Oncology, The Ohio State University, discusses treatment algorithms for metastatic HER2+ breast cancer, a topic discussed at the…
At the virtual 2021 Great Debates & Updates in Women’s Oncology meeting, Shannon N. Westin, MD, MPH, provided an overview on the current and emerging therapies for platinum-resistant ovarian…
Daniel Hayes, MD, discusses his recent debate with Nikhil Wagle, MD, regarding the benefits of extended endocrine therapy.
At the Great Debates & Updates in Women’s Oncology meeting, Shanu Modi, MD, provided insight on personalized treatments for HER2+ breast cancer.
At the Great Debates & Updates in Women's Oncology meeting, Heather McArthur, MD, MPH, participated in a lively debate about the comprehensive use of immunotherapy for TNBC.
From the organizers of Great Debates & Updates, we're excited to announce a new interactive CME series connecting those treating breast and gynecologic cancers.
Stay in the know.
OncNet Newsletter